Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HDAC; histone deacetylase; HDACi; histone deacetylase inhibitors; COX; cyclooxygenases; NSAIDs; non-steroidal anti-inflammatory drugs; AR; androgen receptor; ZBG; zinc binding group; PGE2; prostaglandin E2;
Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors
Keywords: HDAC; histone deacetylase; HDACi; histone deacetylase inhibitors; ZBG; zinc binding group;
Keywords: Histone deacetylase inhibitors; Coumarin; 2-AminoBenzamide; Docking; Molecular dynamics; HDAC; Histone Deacetylases; HATs; Histone Acetyl Transferases; HSP 90; Heat Shock Protein 90; SAHA; suberoylanilide hydroxamic acid; TSA; Trichostatin A; ZBG; Zinc Bi
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects
Keywords: B16F10; murine melanoma cells; CDCl3; deuterated chloroform; CTCL; cutaneous T-cell lymphoma; DCM; dichloromethane; DFT; density functional theory; DMAP; 4-Dimethylaminopyridine; DMEM; Dulbecco's modified Eagle's media; DMF; dimethylformamide; DMSO; dimet
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy
Keywords: 3D QSAR; Three-Dimensional Quantitative Structure-Activity Relationships; BZDs; Benzodiazepine Derivatives; hKDAC; Human Lysine Deacetylase; KDACI; Lysine Deacetylase Inhibitor; NCI; National Cancer Institute; NEt3; Triethylamine; SLAs; Simplified Largazo
Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions
Keywords: Plasmodium falciparum; Malaria; Aminopeptidase inhibitors; Hydroxamic acid; Zinc-binding group; MAP; metalloaminopeptidase; ZBG; zinc binding group; Pf; Plasmodium falciparum; Dd2 SpiroR; NITD609-RDd2 clone#2; CDI; carbonyldiimidazole; FCC; flash column c
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy
Keywords: Bisthiazole; Histone deacetylases; ZBG; Trifluoromethyl ketones;
A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [18F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging
Keywords: ACN; acetonitrile; AcOH; acetic acid; ADAM; a disintegrin and metalloproteinase; CD; catalytic domain; DCC; N,Nâ²-dicyclohexylcarbodiimide; DCM; dichloromethane; DMF; N,N-dimethylformamide; ECM; extracellular matrix; EOB; end of bombardment; EOS; end of
Saccharin: A lead compound for structure-based drug design of carbonic anhydrase IX inhibitors
Keywords: CA; carbonic anhydrase; Ki; inhibition constant; ZBG; zinc binding group; Saccharin; Metalloenzyme; Carbonic anhydrase IX; CA IX-mimic; Structure-based drug design;
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9
Keywords: MMP; Gelatinases; ZBG; QSAR; Molecular docking
New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors
Keywords: BSA; benzenesulfonamide; HPM; hydroxypyrimidinone; CA; carbonic anhydrase; MMP; matrix metalloproteinase; ZBG; zinc-binding group; HA; hydroxamic acid; Hydroxypyrimidinones; Carbonic anhydrase inhibitors; Sulfonamides; MMP inhibitors;